| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 06/26/2008 | WO2008075048A2 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments |
| 06/26/2008 | WO2008055970A3 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 06/26/2008 | US20080154043 Adenosine receptor ligand intermediates; lipase enzymatic hydrolysis and resolution of racemic exoester forming enantiomerically pure 7 acid and 6R ester; claimed [exo]-7-oxabicyclo [2.2.1]heptane-2-carboxylic acid butyl ester |
| 06/26/2008 | US20080153901 Treating and/or preventing rosacea, common acne and/or seborrhoeic dermatitis. |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| 06/26/2008 | CA2673591A1 Chemical compounds |
| 06/25/2008 | EP1935893A1 Total synthesis of pladienolide b and pladienolide d |
| 06/25/2008 | CN101208346A Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors |
| 06/25/2008 | CN101205233A Dimeric flavone compound as well as preparation and uses thereof |
| 06/25/2008 | CN101205232A Technical new method for extracting artemisinin from sweet wormwood plants by ultrasonic assistance |
| 06/25/2008 | CN101205225A Method for preparing lactones by biomimetic catalytic oxidation of ketone compounds |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/19/2008 | WO2008073764A2 Substantially pure fluorescein |
| 06/19/2008 | WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | WO2008071981A1 Piperidines for the treatment of bacterial infections |
| 06/19/2008 | WO2008071961A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 06/19/2008 | CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 06/19/2008 | CA2671860A1 Process for preparing substantially pure fluorescein |
| 06/19/2008 | CA2671485A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/18/2008 | EP1931681A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 06/18/2008 | EP1222192B1 Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor |
| 06/18/2008 | CN101199452A Novel compounds and their uses in fragrance applications |
| 06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
| 06/17/2008 | US7387800 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 06/17/2008 | CA2276532C Frangible compounds for pathogen inactivation |
| 06/12/2008 | WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/12/2008 | US20080139826 Method For Manufacturing Fullerene Derivatives |
| 06/12/2008 | CA2671179A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/11/2008 | EP1930334A1 The compounds 6-oxabicylco[3.2.1] octane, 5-methyl-1-(1,2,2-trimethylbicyclo[3.1.0] hex-3-yl)-, 2-oxabicyclo[2,2,2]octane, 1-methyl-4-(1,2,2-trimethylbicyclo[3,1,0] hex-3-yl)-, and their uses in fragrance applications |
| 06/11/2008 | EP1930333A1 Method and apparatus for producing episesamin-rich composition |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/10/2008 | US7385067 Process for the preparation of compounds having a CF2O bridge |
| 06/10/2008 | US7384975 Substituted furochromenes, preparation thereof and their antiinflammatory action |
| 06/10/2008 | US7384964 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/10/2008 | US7384947 Treating cancer with anticarcinogenic agents 3-Amino-9-chloro-5,6,7,8-tetrahydro-naphtho[2,3-b]furan-2-yl))-(2-methyl-pyridin-3-yl)-methanone; antiproliferative agents |
| 06/10/2008 | CA2146669C Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes |
| 06/05/2008 | WO2008066153A1 Pest control agent |
| 06/05/2008 | WO2008064558A1 Bromo-dihydroartemisinin and its preparation |
| 06/05/2008 | US20080132566 Metabolic Syndrome-Improving Agent and Medicine, Supplement, Functional Food and Food Additive Containing the Same |
| 06/05/2008 | US20080132565 Polycyclic Macrolactones |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | DE102006057036A1 New biphenyl substituted spirocyclic ketoenol derivatives useful for the manufacture of herbicides and for combating parasites |
| 06/04/2008 | EP1594878B1 Avermectin monosaccharide derivatives having pesticidal properties |
| 06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/04/2008 | CN101190920A Method for preparing 3-dibutylamino-6-methyl-7-anilinfluorane |
| 06/04/2008 | CN101190919A Method for extracting and preparing sesamin by using HZ816 modified resin |
| 06/04/2008 | CN101190258A Total sesquiterpene lactone extract containing rich parthenolide and preparation method and application thereof |
| 05/29/2008 | WO2008046109A3 Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer |
| 05/29/2008 | US20080125586 probes, modulators or detectors of the activity of cytochrome P450 monooxygenase enzyme system, used for high throughput drug screenning |
| 05/29/2008 | US20080125411 Dispiro 1,2,4-trioxolane antimalarials |
| 05/29/2008 | DE102006055470A1 Ketomethioninketale und deren Derivate Ketomethionine and their derivatives |
| 05/28/2008 | CN101188937A Pest control agents |
| 05/28/2008 | CN101186610A Leucinocaine 10-O-(dimethylaminoethyl)ginkgolide B semihydrate crystal and preparation method thereof |
| 05/28/2008 | CN101185692A Nauclea officinalis extract and preparation and use thereof |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390167C Total synthesis of myriaporones |
| 05/27/2008 | US7378534 Anti-first-pass effect compounds |
| 05/27/2008 | US7378519 enantiomerically pure 1S,2S-tramadol hydrochloride by dissolving topiramate and tramadol hydrochloride; cooling; crystallization; filtration; separating the 1S,2S-tramadol hydrochloride from the mother liquor by chromatography or crystallization |
| 05/27/2008 | US7378441 Resistance-repellent retroviral protease inhibitors |
| 05/27/2008 | US7378419 3-{[(5,5a,8a,9)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]amino}-1-methyl-1H-pyrrole-2,5-dione; anticarcinogenic agent; inhibiting catalytic activity of topoisomerase II by stabilization of cleavable complex; better soluble and tolerated |
| 05/22/2008 | WO2008060767A2 Macrocyclic benzofused pyrimidine derivatives |
| 05/22/2008 | WO2008059837A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 05/22/2008 | US20080119659 Fluorinated bis (phthalic anhydride) and method for producing the same |
| 05/22/2008 | US20080119543 Method of purifying moxidectin through crystallization |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119541 Novel genes encoding a nystatin polyketide synthase and their manipulation and utility |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/21/2008 | EP1603557A4 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 05/21/2008 | CN101184756A Isoflavonoid dimers |
| 05/21/2008 | CN101182325A Intravenous administration bilobalide B and extraction method |
| 05/21/2008 | CN101182324A Method for synthesizing spiro ketal by employing double organic zincons |
| 05/21/2008 | CN101181469A Osteosporosis-resistance chinese medicine extract as well as extracting technique and usage of active component |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375132 Compounds and methods for inhibiting cellular responses to hypoxia |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/15/2008 | WO2008055970A2 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 05/15/2008 | US20080114189 Cyclisation Process |
| 05/15/2008 | US20080114040 Epothilone Derivatives |
| 05/15/2008 | US20080113941 4-O esters of podophyllotoxin and 4'-demethylepipodophyllotoxin 4'-phosphonic acid or phosphonate derivatives; anticancer agents; type II DNA topoisomerase (topoisomerase II) inhibitors |
| 05/15/2008 | CA2669014A1 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 05/14/2008 | EP1920370A2 Drug, drug guidance system, magnetic detection system, and drug design method |
| 05/14/2008 | EP1919889A2 Sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 05/14/2008 | CN101177425A Novel epothilones compound as well as preparation method and use thereof |
| 05/14/2008 | CN100387604C Triptolide purification method |
| 05/14/2008 | CN100387603C Eremophil dilactone natural product with tumour cell growth inhibiting activity |
| 05/13/2008 | US7371875 Compounds based on 3,7-dioxo-2-aza-6-oxabicyclo(3.2.0)heptane; proteosome inhibitors for treating proliferative or inflammatory disorders with better stability, toxicity and/or oral bioavailability |
| 05/13/2008 | US7371778 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 05/13/2008 | US7371548 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with polyketide biosynthesis for use in identifying modulators of immune response and cell proliferative disorders and which prevent propagation of insects, fungi and parasites |
| 05/13/2008 | CA2469343C Combination of cytochome p450 dependent protease inhibitors |
| 05/08/2008 | WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 05/08/2008 | WO2008053206A2 Process for preparation of aldonic acids and derivatives thereof |
| 05/08/2008 | WO2008034598A8 Method for the synthesis of hexahydrofuro (2, 3-b) furan-3-ol compounds |
| 05/08/2008 | US20080108838 Novel chiral heptyne derivatives for the preparation of epothilones and processes for their preparation |